Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

A novel serum metabolomics-based diagnostic approach for colorectal cancer.

Nishiumi S, Kobayashi T, Ikeda A, Yoshie T, Kibi M, Izumi Y, Okuno T, Hayashi N, Kawano S, Takenawa T, Azuma T, Yoshida M.

PLoS One. 2012;7(7):e40459. doi: 10.1371/journal.pone.0040459. Epub 2012 Jul 11.

2.

Investigations in the possibility of early detection of colorectal cancer by gas chromatography/triple-quadrupole mass spectrometry.

Nishiumi S, Kobayashi T, Kawana S, Unno Y, Sakai T, Okamoto K, Yamada Y, Sudo K, Yamaji T, Saito Y, Kanemitsu Y, Okita NT, Saito H, Tsugane S, Azuma T, Ojima N, Yoshida M.

Oncotarget. 2017 Mar 7;8(10):17115-17126. doi: 10.18632/oncotarget.15081.

3.

A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics.

Farshidfar F, Weljie AM, Kopciuk KA, Hilsden R, McGregor SE, Buie WD, MacLean A, Vogel HJ, Bathe OF.

Br J Cancer. 2016 Sep 27;115(7):848-57. doi: 10.1038/bjc.2016.243. Epub 2016 Aug 25.

PMID:
27560555
4.

Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection.

Ritchie SA, Ahiahonu PW, Jayasinghe D, Heath D, Liu J, Lu Y, Jin W, Kavianpour A, Yamazaki Y, Khan AM, Hossain M, Su-Myat KK, Wood PL, Krenitsky K, Takemasa I, Miyake M, Sekimoto M, Monden M, Matsubara H, Nomura F, Goodenowe DB.

BMC Med. 2010 Feb 15;8:13. doi: 10.1186/1741-7015-8-13.

5.

Serum metabolomic profiling of prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.

Huang J, Mondul AM, Weinstein SJ, Koutros S, Derkach A, Karoly E, Sampson JN, Moore SC, Berndt SI, Albanes D.

Br J Cancer. 2016 Oct 25;115(9):1087-1095. doi: 10.1038/bjc.2016.305. Epub 2016 Sep 27.

6.

A novel serum metabolomics-based diagnostic approach to pancreatic cancer.

Kobayashi T, Nishiumi S, Ikeda A, Yoshie T, Sakai A, Matsubara A, Izumi Y, Tsumura H, Tsuda M, Nishisaki H, Hayashi N, Kawano S, Fujiwara Y, Minami H, Takenawa T, Azuma T, Yoshida M.

Cancer Epidemiol Biomarkers Prev. 2013 Apr;22(4):571-9. doi: 10.1158/1055-9965.EPI-12-1033. Epub 2013 Mar 29.

7.

A novel gas chromatography mass spectrometry-based serum diagnostic and assessment approach to ulcerative colitis.

Kohashi M, Nishiumi S, Ooi M, Yoshie T, Matsubara A, Suzuki M, Hoshi N, Kamikozuru K, Yokoyama Y, Fukunaga K, Nakamura S, Azuma T, Yoshida M.

J Crohns Colitis. 2014 Sep;8(9):1010-21. doi: 10.1016/j.crohns.2014.01.024. Epub 2014 Feb 26.

PMID:
24582087
8.

A plasma microRNA panel for early detection of colorectal cancer.

Wang S, Xiang J, Li Z, Lu S, Hu J, Gao X, Yu L, Wang L, Wang J, Wu Y, Chen Z, Zhu H.

Int J Cancer. 2015 Jan 1;136(1):152-61. doi: 10.1002/ijc.28136. Epub 2014 Apr 25.

9.

Head-to-Head Comparison and Evaluation of 92 Plasma Protein Biomarkers for Early Detection of Colorectal Cancer in a True Screening Setting.

Chen H, Zucknick M, Werner S, Knebel P, Brenner H.

Clin Cancer Res. 2015 Jul 15;21(14):3318-26. doi: 10.1158/1078-0432.CCR-14-3051. Epub 2015 May 26.

10.

Metabonomics identifies serum metabolite markers of colorectal cancer.

Tan B, Qiu Y, Zou X, Chen T, Xie G, Cheng Y, Dong T, Zhao L, Feng B, Hu X, Xu LX, Zhao A, Zhang M, Cai G, Cai S, Zhou Z, Zheng M, Zhang Y, Jia W.

J Proteome Res. 2013 Jun 7;12(6):3000-9. doi: 10.1021/pr400337b. Epub 2013 May 29.

PMID:
23675754
11.

[Clinical significance of the detection of serum neutrophil gelatinase-associated lipocalin in human colorectal cancer].

Ding L, Zhang X, Zhang Y, Yang G, Liao X, Shen Z, Qiu J, Mao W, Hu L, Shao S, Shang S.

Zhonghua Wei Chang Wai Ke Za Zhi. 2014 Jun;17(6):589-93. Chinese.

PMID:
24953369
12.

Serum metabolomics as a novel diagnostic approach for gastrointestinal cancer.

Ikeda A, Nishiumi S, Shinohara M, Yoshie T, Hatano N, Okuno T, Bamba T, Fukusaki E, Takenawa T, Azuma T, Yoshida M.

Biomed Chromatogr. 2012 May;26(5):548-58. doi: 10.1002/bmc.1671. Epub 2011 Jul 20.

PMID:
21773981
13.

A Plasma-Based Protein Marker Panel for Colorectal Cancer Detection Identified by Multiplex Targeted Mass Spectrometry.

Jones JJ, Wilcox BE, Benz RW, Babbar N, Boragine G, Burrell T, Christie EB, Croner LJ, Cun P, Dillon R, Kairs SN, Kao A, Preston R, Schreckengaust SR, Skor H, Smith WF, You J, Hillis WD, Agus DB, Blume JE.

Clin Colorectal Cancer. 2016 Jun;15(2):186-194.e13. doi: 10.1016/j.clcc.2016.02.004. Epub 2016 Mar 25.

14.

Low-mass-ion discriminant equation: a new concept for colorectal cancer screening.

Lee JH, Kim KH, Park JW, Chang HJ, Kim BC, Kim SY, Kim KG, Lee ES, Kim DY, Oh JH, Yoo BC, Kim IH.

Int J Cancer. 2014 Apr 15;134(8):1844-53. doi: 10.1002/ijc.28517. Epub 2013 Oct 21.

15.

Metabolic system alterations in pancreatic cancer patient serum: potential for early detection.

Ritchie SA, Akita H, Takemasa I, Eguchi H, Pastural E, Nagano H, Monden M, Doki Y, Mori M, Jin W, Sajobi TT, Jayasinghe D, Chitou B, Yamazaki Y, White T, Goodenowe DB.

BMC Cancer. 2013 Sep 12;13:416. doi: 10.1186/1471-2407-13-416.

16.

The metabolomic detection of lung cancer biomarkers in sputum.

Cameron SJ, Lewis KE, Beckmann M, Allison GG, Ghosal R, Lewis PD, Mur LA.

Lung Cancer. 2016 Apr;94:88-95. doi: 10.1016/j.lungcan.2016.02.006. Epub 2016 Feb 8.

PMID:
26973212
17.

Distinct urinary metabolic profile of human colorectal cancer.

Cheng Y, Xie G, Chen T, Qiu Y, Zou X, Zheng M, Tan B, Feng B, Dong T, He P, Zhao L, Zhao A, Xu LX, Zhang Y, Jia W.

J Proteome Res. 2012 Feb 3;11(2):1354-63. doi: 10.1021/pr201001a. Epub 2011 Dec 28.

PMID:
22148915
18.

The evaluation of diagnostic value of the tumor markers: CCSA-2 and CEA in colorectal cancer.

Knychalski B, LukieŇĄczuk T.

Pol Przegl Chir. 2012 Feb;84(2):86-92. doi: 10.2478/v10035-012-0014-3.

PMID:
22487741
19.

A prospective study of serum metabolites and colorectal cancer risk.

Cross AJ, Moore SC, Boca S, Huang WY, Xiong X, Stolzenberg-Solomon R, Sinha R, Sampson JN.

Cancer. 2014 Oct 1;120(19):3049-57. doi: 10.1002/cncr.28799. Epub 2014 Jun 3.

20.

[Study on specific metabonomic profiling of serum from colorectal cancer patients by gas chromatography-mass spectrometry].

Ma YL, Liu WJ, Peng JY, Zhang P, Chen HQ, Qin HL.

Zhonghua Wei Chang Wai Ke Za Zhi. 2009 Jul;12(4):386-90. Chinese.

PMID:
19598026

Supplemental Content

Support Center